Riggs McCoy Profile

User's Picture
Physician-scientists in the Cancer Center at Children's Hospital of  Philadelphia  (CHOP) have developed a preclinical, potent therapy attached to an antibody that targets a surface protein expressed in most childhood neuroblastomas, successfully killing